Mortality and cancer incidence in 263 patients with ataxia-telangiectasia

Journal of the National Cancer Institute

Volumn 77, Issue 1, 1986, Pages 89-92

  Morrell, Daphne ^a   Cromartie, Elizabeth ^a   Swift, Michael ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA TELANGIECTASIA; CANCER INCIDENCE; EPIDEMIOLOGY; ETIOLOGY; FATALITY; HUMAN; LYMPHATIC SYSTEM; LYMPHOMA; MORTALITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ATAXIA TELANGIECTASIA; BLACKS; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; FEMALE; HOMOZYGOTE; HUMAN; INFANT; LEUKEMIA; LYMPHOMA; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; WHITES;

EID: 0022472723     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/77.1.89     Document Type: Article

References (16)

1. SPECTOR BD, FILIPOVICH AH, PERRY GS III, et al. Epidemiologyof cancer in ataxia-telangiectasia. In: Bridges BA, Harnden DG, eds. Ataxia-telangiectasia: A cellular and molecular link between cancer, neuropathology, and immune deficiency. New York: Wiley, 1982:103-138
2. SWIFT M, SHOLMAN L, PERRY M, et al. Malignant neoplasms inthe families of patients with ataxia-telangiectasia. Cancer Res 1976; 36:209-215
3. YOUNG JL, Jr, PERCY CL, ASIRE AJ, eds. Surveillance, epidemiology, and end results: Incidence and mortality data, 1973-77. Natl Cancer Inst Monogr 1981; 57:1-1082
4. MONSON RR. Analysis of relative survival and proportionalmortality. Comput Biomed Res 1974; 7:325-332
5. MANTEL N, HAENSZEL W. Statistical aspects of the analysis ofdata from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748
6. LEE ET. Statistical methods for survival data analysis. Belmont, CA: Lifetime Learning Publ, 1980:88-96
7. SEDGWICK RP, BODER E. Ataxia-telangiectasia. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. New York: American Elsevier, 1972; 14:267-339
8. HARRIS VJ, SEELER RA. Ataxia-telangiectasia and Hodgkin’s disease. Cancer 1973; 32:1415-1420
9. TOLEDANO SR, LANGE BJ. Ataxia-telangiectasia and acute lymphoblastic leukemia. Cancer 1980; 45:1675-1678
10. SAXON A, STEVENS RH, GOLDE DW. Helper and suppressorT-lymphocyle leukemia in ataxia-telangiectasia. N Engl J Med 1979; 300:700-704
11. KUMAR GK, AL SAADI A, YANG S-S, et al. Ataxia-telangiectasiaand hepatocellular carcinoma. Am J Med Sci 1979; 278:157-160
12. ABADIR R, HAKAMI N. Ataxia telangiectasia with cancer. Anindication for reduced radiotherapy and chemotherapy doses. Br J Radiol 1983; 56:343-345
13. AMROMIN GD, BODER E, TEPLITZ R. Ataxia-telangiectasia with a32 year survival. A clinicopathological report. J Neuropathol Exp Neurol 1979; 38:621-643
14. GATTI R, GOOD RA. Occurrence of malignancy in immunodeficiency diseases. Cancer 1971; 28:89-98
15. PERRY GS III, SPECTOR BD, SCHUMAN LM, et al. The Wiskott-Aldrich syndrome in the United Slates and Canada (1892-1979). J Pediatr 1980; 97:72-78
16. KINLEN LJ, WEBSTER AD, BIRD AG, et al. Prospective study ofcancer in patients with hypogammaglobulinaemia. Lancet 1985; 1:263-266